Literature DB >> 32871778

Do TRIB1 and IL-9 Gene Polymorphisms Impact the Development and Manifestation of Pituitary Adenoma?

Tomas Mickevicius1, Alvita Vilkeviciute2, Brigita Glebauskiene2, Loresa Kriauciuniene2, Rasa Liutkeviciene2.   

Abstract

BACKGROUND/AIM: To evaluate the association between TRIB1(rs6987702) and IL-9(rs1859430, rs2069870) genotypes with the development and manifestation of pituitary adenoma (PA).
MATERIALS AND METHODS: The study group included 141 patients with PA and the control group consisted of 287 healthy people. The genotyping of rs6987702, rs1859430 and rs2069870 was carried out using a real-time polymerase chain reaction.
RESULTS: Statistically significant results were obtained regarding the rs1859430, but there were no significant results regarding rs6987702. We found that the rs1859430 A/A genotype increased the odds of having recurrent PA six times (p=0.006) under the co-dominant model and four times (p=0.021) under the recessive model. Furthermore, the analysis showed that the G/A genotype increased the odds of having recurrent PA 2.3 times (p=0.003) under the co-dominant model, while G/A and A/A genotypes increased the odds 2.7 times (p=0.011) under the over-dominant model.
CONCLUSION: Certain genotypes of rs1859430 can be associated with PA recurrence. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  IL-9 rs1859430; Pituitary adenoma; TRIB1 rs6987702 gene polymorphism; recurrence; rs2069870 gene polymorphism

Mesh:

Substances:

Year:  2020        PMID: 32871778      PMCID: PMC7652474          DOI: 10.21873/invivo.12066

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  47 in total

1.  Identification of putative target genes for amplification within 11q13.2 and 3q27.1 in esophageal squamous cell carcinoma.

Authors:  Z-Z Shi; Y-Y Jiang; J-J Hao; Y Zhang; T-T Zhang; L Shang; S-G Liu; F Shi; M-R Wang
Journal:  Clin Transl Oncol       Date:  2013-11-08       Impact factor: 3.405

Review 2.  The role of Trib1 in myeloid leukaemogenesis and differentiation.

Authors:  Takuro Nakamura
Journal:  Biochem Soc Trans       Date:  2015-10       Impact factor: 5.407

3.  Gene profiling identifies genes specific for well-differentiated epithelial thyroid tumors.

Authors:  L G Puskas; F Juhasz; A Zarva; L Hackler; N R Farid
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2005-09-05       Impact factor: 1.770

Review 4.  Th9 cells in the pathogenesis of EAE and multiple sclerosis.

Authors:  Wassim Elyaman; Samia J Khoury
Journal:  Semin Immunopathol       Date:  2016-11-14       Impact factor: 9.623

Review 5.  Interleukin-9 and T helper type 9 cells in rheumatic diseases.

Authors:  F Ciccia; G Guggino; A Ferrante; P Cipriani; R Giacomelli; G Triolo
Journal:  Clin Exp Immunol       Date:  2016-08       Impact factor: 4.330

6.  Associations of cholesteryl ester transfer protein (CETP) gene variants with pituitary adenoma.

Authors:  Agne Sidaraite; Rasa Liutkeviciene; Brigita Glebauskiene; Alvita Vilkeviciute; Loresa Kriauciuniene
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2019-04-17       Impact factor: 1.245

7.  Interleukin-9 expression in human malignant lymphomas: unique association with Hodgkin's disease and large cell anaplastic lymphoma.

Authors:  H Merz; F A Houssiau; K Orscheschek; J C Renauld; A Fliedner; M Herin; H Noel; M Kadin; H K Mueller-Hermelink; J Van Snick
Journal:  Blood       Date:  1991-09-01       Impact factor: 22.113

8.  Expression cloning of the murine and human interleukin 9 receptor cDNAs.

Authors:  J C Renauld; C Druez; A Kermouni; F Houssiau; C Uyttenhove; E Van Roost; J Van Snick
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

9.  Interleukin 9 is expressed by primary and cultured Hodgkin and Reed-Sternberg cells.

Authors:  H J Gruss; M A Brach; H G Drexler; K J Bross; F Herrmann
Journal:  Cancer Res       Date:  1992-02-15       Impact factor: 12.701

10.  TRIB1 promotes colorectal cancer cell migration and invasion through activation MMP-2 via FAK/Src and ERK pathways.

Authors:  Yuhui Wang; Nan Wu; Bo Pang; Dandan Tong; Donglin Sun; Haiming Sun; Chunyu Zhang; Wenjing Sun; Xiangning Meng; Jing Bai; Feng Chen; Jingshu Geng; Songbin Fu; Yan Jin
Journal:  Oncotarget       Date:  2017-07-18
View more
  4 in total

1.  IL-9 and IL-10 Single-Nucleotide Variants and Serum Levels in Age-Related Macular Degeneration in the Caucasian Population.

Authors:  Alvita Vilkeviciute; Dzastina Cebatoriene; Loresa Kriauciuniene; Reda Zemaitiene; Rasa Liutkeviciene
Journal:  Mediators Inflamm       Date:  2021-04-12       Impact factor: 4.711

2.  IL-10 Gene Rs1800871, Rs1800872, and Rs1800896 Polymorphisms and IL-10 Serum Levels Association with Pituitary Adenoma.

Authors:  Migle Palivonaite; Greta Gedvilaite; Brigita Glebauskiene; Loresa Kriauciuniene; Vita Rovite; Rasa Liutkeviciene
Journal:  Biomedicines       Date:  2022-08-08

3.  TBX15 rs98422, DNM3 rs1011731, RAD51B rs8017304, and rs2588809 Gene Polymorphisms and Associations With Pituitary Adenoma.

Authors:  Gabija JuknytĖ; Inga LaurinaitytĖ; Alvita VilkeviČiŪtĖ; Greta GedvilaitĖ; Brigita GlebauskienĖ; Loresa KriauČiŪnienĖ; Rasa LiutkeviČienĖ
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

4.  The Role of IL-9 Polymorphisms and Serum IL-9 Levels in Carcinogenesis and Survival Rate for Laryngeal Squamous Cell Carcinoma.

Authors:  Agne Pasvenskaite; Rasa Liutkeviciene; Greta Gedvilaite; Alvita Vilkeviciute; Vykintas Liutkevicius; Virgilijus Uloza
Journal:  Cells       Date:  2021-03-09       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.